M&A Deal Summary

Hangzhou Tigermed Consulting Co Acquires Marti Farm

On January 19, 2023, Hangzhou Tigermed Consulting Co acquired life science company Marti Farm

Acquisition Highlights
  • This is Hangzhou Tigermed Consulting Co’s 2nd transaction in the Life Science sector.
  • This is Hangzhou Tigermed Consulting Co’s 1st transaction in Croatia.

M&A Deal Summary

Date 2023-01-19
Target Marti Farm
Sector Life Science
Buyer(s) Hangzhou Tigermed Consulting Co
Deal Type Add-on Acquisition

Target

Marti Farm

Zagreb, Croatia
Marti Farm is a contract research organization dedicated to assisting the healthcare, pharmaceutical, and food supplement sectors in developing and delivering health-improving outcomes. Marti Farm is based in Zagreb, Croatia.

Search 214,238 Deals Now

SEARCH BY

  • Buyer Type (PE or Strategic)
  • Deal Size ($10M to $10B+)
  • Sector (60 Sectors)
  • Deal Type
  • Geography
  • & More

Try Free

Buyer(S) 1

Buyer

Hangzhou Tigermed Consulting Co

Hangzhou, China

Category Company
Founded 2004
Sector Life Science
DESCRIPTION

Hangzhou Tigermed Consulting Co., Ltd. operates as a contract research organization in the People’s Republic of China.


DEAL STATS #
Overall 2 of 3
Sector: Life Science M&A 2 of 3
Type: Add-on Acquisition M&A Deals 2 of 3
Country: Croatia M&A 1 of 1
Year: 2023 M&A 1 of 1
PREVIOUS DEAL
DATE TARGET DEAL TYPE VALUE
2014-07-30 Frontage Laboratories

Exton, Pennsylvania, United States

Frontage is a US - China contract research organization that provides research services to facilitate pharmaceutical discovery, development and commercialization for large and emerging pharmaceutical and biotechnology companies. The Company has facilities in Pennsylvania (Malvern and Exton) and in China (Shanghai).

Buy -
FOLLOWING DEAL
DATE TARGET DEAL TYPE VALUE
2025-07-29 Micron

Tokyo, Japan

Micron is a Contract Research Organization (CRO) focusing on medical imaging and clinical trial services. The company globally supports the development of pharmaceuticals, diagnostics, medical devices, biomarkers, and AI-guided SaMD through a range of clinical development services centered around medical imaging. Micron provides support across various aspects of clinical development, including monitoring, quality control, imaging core lab operations, image analysis, and centralized imaging review. It also serves as an In-Country Clinical Caretaker (ICCC), offering tailored assistance to foreign medtech and biotech companies conducting clinical trials in Japan. Micron was formed in 2005 and is based in Tokyo, Japan.

Buy -